Is noradrenaline a significant factor in the analgesic effect of antidepressants?

Pain

Volumn 106, Issue 1-2, 2003, Pages 3-8

  Jasmin, Luc ^a,b   Tien, Duc ^a   Janni, Gabriela ^b   Ohara, Peter T ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adrenoreceptors; Analgesia; Noradrenaline reuptake; Norepinephrine; Pain

Indexed keywords

ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; CARBIDOPA; CLONIDINE; DESIPRAMINE; DEXMEDETOMIDINE; DOXEPIN; IMIPRAMINE; NORADRENALIN; NORADRENALIN UPTAKE INHIBITOR; OPIATE; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; THREO 3,4 DIHYDROXYPHENYLSERINE; TIZANIDINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; YOHIMBINE;

ANALGESIA; ANTINOCICEPTION; CHRONIC PAIN; CLINICAL TRIAL; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; LONG TERM CARE; NEUROPATHIC PAIN; NONHUMAN; NORADRENALIN UPTAKE; NORADRENERGIC SYSTEM; PAIN THRESHOLD; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; THEORY;

EID: 0142165209     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2003.08.010     Document Type: Review

References (64)

1. Abad F., Feria M., Boada J. Chronic amitriptyline decreases autotomy following dorsal rhizotomy in rats. Neurosci Lett. 99:1989;187-190.
2. Ackerman L.L., Follett K.A., Rosenquist R.W. Long-term outcomes during treatment of chronic pain with intrathecal clonidine or clonidine/opioid combinations. J Pain Symptom Management. 26:2003;668-677.
3. Al-Adawi S., Dawe G.S., Bonner A., Stephenson J.D., Zarei M. Central noradrenergic blockade prevents autotomy in rat: implication for pharmacological prevention of postdenervation pain syndrome. Brain Res Bull. 57:2002;581-586.
4. Ardid D., Guilbaud G. Antinociceptive effects of acute and 'chronic' injections of tricyclic antidepressant drugs in a new model of mononeuropathy in rats. Pain. 49:1992;279-287.
5. Atkinson J.H., Slater M.A., Williams R.A., Zisook S., Patterson T.L., Grant I., Wahlgren D.R., Abramson I., Garfin S.R. A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain. Pain. 76:1998;287-296.
6. Baba H., Goldstein P.A., Okamoto M., Kohno T., Ataka T., Yoshimura M., Shimoji K. Norepinephrine facilitates inhibitory transmission in substantia gelatinosa of adult rat spinal cord (part 2): effects on somatodendritic sites of GABAergic neurons. Anesthesiology. 92:2000;485-492.
7. Bennett R.M. Antidepressants do not have better results than placebo in the treatment of fibromyalgia in Brazil. Curr Rheumatol Rep. 4:2002;284-285.
8. Bohn L.M., Xu F., Gainetdinov R.R., Caron M.G. Potentiated opioid analgesia in norepinephrine transporter knock-out mice. J Neurosci. 20:2000;9040-9045.
9. Butler S.H., Weil-Fugazza J., Godefroy F., Besson J.M. Reduction of arthritis and pain behaviour following chronic administration of amitriptyline or imipramine in rats with adjuvant-induced arthritis. Pain. 23:1985;159-175.
10. Cardenas D.D., Warms C.A., Turner J.A., Marshall H., Brooke M.M., Loeser J.D. Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trial. Pain. 96:2002;365-373.
11. Chapman C.R., Butler S.H. Effects of doxepin on perception of laboratory-induced pain in man. Pain. 5:1978;253-262.
12. Coghill R.C., McHaffie J.G., Yen Y.F. Neural correlates of interindividual differences in the subjective experience of pain. Proc Natl Acad Sci USA. 2003.
13. Conti A.C., Cryan J.F., Dalvi A., Lucki I., Blendy J.A. cAMP response element-binding protein is essential for the upregulation of brain-derived neurotropic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. J Neurosci. 22:2002;3262-3268.
14. Enggaard T.P., Klitgaard N.A., Gram L.F., Arendt-Nielsen L., Sindrup S.H. Specific effect of venlafaxine on single and repetitive experimental painful stimuli in humans. Clin Pharmacol Ther. 69:2001;245-251.
15. Eschalier A., Ardid D., Dubray C. Tricyclic and other antidepressants as analgesics. Sawynok J., Cowan A. Novel aspects of pain management: opioids and beyond. 1999;303-319 Wiley, New York.
16. Esser M.J., Chase T., Allen G.V., Sawynok J. Chronic administration of amitriptyline and caffeine in a rat model of neuropathic pain: multiple interactions. Eur J Pharmacol. 430:2001;211-218.
17. Ghelardini C., Galeotti N., Bartolini A. Antinociception induced by amitriptyline and imipramine is mediated by α2A-adrenoceptors. Jpn J Pharmacol. 82:2000;130-137.
18. Godefroy F., Butler S.H., Weil-Fugazza J., Besson J.M. Do acute or chronic tricyclic antidepressants modify morphine antinociception in arthritic rats? Pain. 25:1986;233-244.
19. Gray A.M., Pache D.M., Sewell R.D. Do α2-adrenoceptors play an integral role in the antinociceptive mechanism of action of antidepressant compounds? Eur J Pharmacol. 378:1999;161-168.
20. Gulwadi A.G., Hoane M.R., Saydoff J.A., Frydel B.R., Lindner M.D. No detectable analgesic effects in the formalin test even with one million bovine adrenal chromaffin cells. Pain. 99:2002;263-271.
21. Hassenbusch S.J., Garber J., Buchser E., Du Pen S., Nitescu P. Alternative intrathecal agents for the treatment of pain. Neuromodulation. 2:1999;85-91.
22. Hindmarch I. Expanding the horizons of depression: beyond the monoamine hypothesis. Hum Psychopharmacol. 16:2001;203-218.
23. Hopwood S.E., Stamford J.A. Noradrenergic modulation of serotonin release in rat dorsal and median raphe nuclei via α(1) and α(2A) adrenoceptors. Neuropharmacology. 41:2001;433-442.
24. Jasmin L., Boudah A., Ohara P.T. Long-term effects of decreased noradrenergic central nervous system innervation on pain behavior and opioid antinociception. J Comp Neurol. 460:2003;38-55.
25. Jasmin L., Tien D., Weinshenker D., Palmiter R.D., Green P.G., Janni G., Ohara P.T. The NK1 receptor mediates both the hyperalgesia and the resistance to morphine in mice lacking noradrenaline. Proc Natl Acad Sci USA. 99:2002;1029-1034.
26. Kawabata A., Kasamatsu K., Umeda N., Takagi H. The noradrenaline precursor L-threo-3,4-dihydroxyphenylserine exhibits antinociceptive activity via central α-adrenoceptors in the mouse. Br J Pharmacol. 111:1994;503-508.
27. Korzeniewska-Rybicka I., Plaznik A. Supraspinally mediated analgesic effect of antidepressant drugs. Pol J Pharmacol. 52:2000;93-99.
28. Li X., Conklin D., Ma, Zhu X., Eisenach J. Spinal noradrenergic activation mediates allodynia reduction from an allosteric adenosine modulator in a rat model of neuropathic pain. Pain. 97:2002;117-125.
29. Lund A., Mjellem-Joly N., Hole K. Chronic administration of desipramine and zimelidine changes the behavioural response in the formalin test in rats. Neuropharmacology. 30:1991;481-487.
30. Mattia C., Paoletti F., Coluzzi F., Boanelli A. New antidepressants in the treatment of neuropathic pain. A review. Minerva Anestesiol. 68:2002;105-114.
31. Max M.B. Antidepressant as Analgesics. Fields H.L., Liebeskind J.C. Pharmacological approaches to the treatment of chronic pain. vol. 1: 1994;229-246 IASP Press, Seattle, WA.
32. McQuay H.J., Tramer M., Nye B.A., Carroll D., Wiffen P.J., Moore R.A. A systematic review of antidepressants in neuropathic pain. Pain. 68:1996;217-227.
33. Mercadante S., Arcuri E., Tirelli W., Villari P., Casuccio A. Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study. Tumori. 88:2002;239-242.
34. Mico J.A., Gibert-Rahola J., Casas J., Rojas O., Serrano M.I., Serrano J.S. Implication of β1- and β2-adrenergic receptors in the antinociceptive effect of tricyclic antidepressants. Eur Neuropsychopharmacol. 7:1997;139-145.
35. Millan M.J. Descending control of pain. Prog Neurobiol. 66:2002;355-474.
36. Monks R., Merskey H. Psychotropic drugs. Wall P.D., Melzack R. Textbook of pain. 1999;1155-1186 Churchill Livingstone, New York.
37. Ongioco R.R., Richardson C.D., Rudner X.L., Stafford-Smith M., Schwinn D.A. α2-Adrenergic receptors in human dorsal root ganglia: predominance of α2b and α2c subtype mRNAs. Anesthesiology. 92:2000;968-976.
38. Page M.E., Lucki I. Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex. Neuropsychopharmacology. 27:2002;237-247.
39. Popoli M., Gennarelli M., Racagni G. Modulation of synaptic plasticity by stress and antidepressants. Bipolar Disord. 4:2002;166-182.
40. Poulsen L., Arendt-Nielsen L., Brosen K., Nielsen K.K., Gram L.F., Sindrup S.H. The hypoalgesic effect of imipramine in different human experimental pain models. Pain. 60:1995;287-293.
41. Rojas-Corrales M.O., Berrocoso E., Gibert-Rahola J., Mico J.A. Antidepressant-like effects of tramadol and other central analgesics with activity on monoamines reuptake, in helpless rats. Life Sci. 72:2002;143-152.
42. Saito K., Kanazawa M., Fukudo S. Colorectal distention induces hippocampal noradrenaline release in rats: an in vivo microdialysis study. Brain Res. 947:2002;146-149.
43. Salerno S.M., Browning R., Jackson J.L. The effect of antidepressant treatment on chronic back pain: a meta-analysis. Arch Intern Med. 162:2002;19-24.
44. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., Weisstaub N., Lee J., Duman R., Arancio O., Belzung C., Hen R. Requirement of hippocamal neurogenesis for the behavioral effect of antidepressants. Science. 301:2003;805-809.
45. Sawynok J., Esser M.J., Reid A.R. Antidepressants as analgesics: an overview of central and peripheral mechanisms of action. J Psychiatry Neurosci. 26:2001;21-29.
46. Sawynok J., Reid A. Interactions of descending serotonergic systems with other neurotransmitters in the modulation of nociception. Behav Brain Res. 73:1996;63-68.
47. Schreiber S., Backer M.M., Pick C.G. The antinociceptive effect of venlafaxine in mice is mediated through opioid and adrenergic mechanisms. Neurosci Lett. 273:1999;85-88.
48. Schreiber S., Rigai T., Katz Y., Pick C.G. The antinociceptive effect of mirtazapine in mice is mediated through serotonergic, noradrenergic and opioid mechanisms. Brain Res Bull. 58:2002;601-605.
49. Shannon H.E., Lutz E.A. Yohimbine produces antinociception in the formalin test in rats: involvement of serotonin(1A) receptors. Psychopharmacology (Berl). 149:2000;93-97.
50. Sierralta F., Pinardi G., Miranda H.F. Effect of p-chlorophenylalanine and α-methyltyrosine on the antinociceptive effect of antidepressant drugs. Pharmacol Toxicol. 77:1995;276-280.
51. Sindrup S.H., Bach F.W., Madsen C., Gram L.F., Jensen T.S. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology. 60:2003;1284-1289.
52. Smith A.J. The analgesic effects of selective serotonin reuptake inhibitors. J Psychopharmacol. 12:1998;407-413.
53. Stone L.S., MacMillan L.B., Kitto K.F., Limbird L.E., Wilcox G.L. The α2a adrenergic receptor subtype mediates spinal analgesia evoked by α2 agonists and is necessary for spinal adrenergic-opioid synergy. J Neurosci. 17:1997;7157-7165.
54. Takagi H., Harima A. Analgesic effect of L-threo-3,4- dihydroxyphenylserine (L-DOPS) in patients with chronic pain. Eur Neuropsychopharmacol. 6:1996;43-47.
55. Tasmuth T., Hartel B., Kalso E. Venlafaxine in neuropathic pain following treatment of breast cancer. Eur J Pain. 6:2002;17-24.
56. Tsuruoka M., Arai Y.C., Nomura H., Matsutani K., Willis W.D. Unilateral hindpaw inflammation induces bilateral activation of the locus coeruleus and the nucleus subcoeruleus in the rat. Brain Res Bull. 61:2003;117-123.
57. Tura B., Tura S.M. The analgesic effect of tricyclic antidepressants. Brain Res. 518:1990;19-22.
58. Vincent S., Robertson D. The broader view: catecholamine abnormalities. Clin Auton Res. 12:(Suppl 1):2002;I44-I49.
59. Wallace M.S., Barger D., Schulteis G. The effect of chronic oral desipramine on capsaicin-induced allodynia and hyperalgesia: a double-blinded, placebo-controlled, crossover study. Anesth Analg. 95:2002;973-978. Table of contents.
60. Xu M., Kontinen V.K., Kalso E. Endogenous noradrenergic tone controls symptoms of allodynia in the spinal nerve ligation model of neuropathic pain. Eur J Pharmacol. 366:1999;41-45.
61. Xu H., Steven Richardson J., Li X.M. Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, Bcl-2 and Cu/Zn-SOD in rat hippocampus. Neuropsychopharmacology. 28:2003;53-62.
62. Yaksh T.L. α-2 adrenergic agonists as analgesic. Sawynok J., Cowan A. Novel aspects of pain management: opioids and beyond. 1999;179-202 Wiley-Liss, New York.
63. Yokogawa F., Kiuchi Y., Ishikawa Y., Otsuka N., Masuda Y., Oguchi K., Hosoyamada A. An investigation of monoamine receptors involved in antinociceptive effects of antidepressants. Anesth Analg. 95:2002;163-168.
64. Zarrindast M.R., Sahebgharani M. Effect of α-adrenoceptor agonists and antagonists on imipramine-induced antinociception in the rat formalin test. Pharmacology. 64:2002;201-207.